20 december 2018
20 december 2018

Xenikos partners with the BMT CTN to conduct a U.S.-based Phase 3 trial to test T-Guard® in aGVHD

Do you like it?
Read more
16 november 2018
16 november 2018

Final results from T-Guard® Phase 1/2 trial in steroid-resistant aGVHD published in journal BBMT

Do you like it?
Read more
14 mei 2018
14 mei 2018

Dutch Company Xenikos Secures USD 30 Million in Series B Financing

Do you like it?
Read more